| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $531.0M | -4.0% |
| Cost of Revenue | $134.9M | -11.9% |
| R&D Expense | $60.8M | -10.7% |
| SG&A Expense | $92.4M | -3.7% |
| Operating Income | -$69.6M | +77.4% |
| Interest Expense | $63.5M | -2.8% |
| Pre-tax Income | -$127.6M | +65.0% |
| Income Tax | -$5.7M | +64.7% |
| Net Income | -$121.9M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.8M | -26.1% |
| Accounts Receivable | $179.0M | -3.6% |
| Current Assets | $332.9M | -13.6% |
| Total Assets | $1.11B | -13.2% |
| Current Liabilities | $377.0M | -8.8% |
| Long-term Debt | $573.3M | -0.7% |
| Stockholders' Equity | $93.8M | -54.4% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $30.0M | +963.3% |
| Capital Expenditures | $1.6M | -61.7% |
| Investing Cash Flow | -$18.4M | +20.3% |
| Financing Cash Flow | -$51.5M | -376.4% |
| Free Cash Flow | $28.4M | +2180.9% |
| +65.1% |
| EPS (Basic) | -$14.87 | +65.7% |